Literature DB >> 26636531

Diagnostic accuracy of adenosine deaminase for tuberculous pericarditis: a meta-analysis.

D L Xie1, B Cheng, Y Sheng, J Jin.   

Abstract

OBJECTIVE: Many studies suggest that adenosine deaminase is a marker for tuberculous pericarditis, while controversy exists as to its diagnostic utility. This study aims to summarize the overall diagnostic performance of adenosine deaminase for tuberculous pericarditis through a meta-analysis.
MATERIALS AND METHODS: Literatures published before May 2015 were searched in PubMed and EMBASE. The data were retrieved and the sensitivity, specificity, positive/negative likelihood ratio (PLR/NLR), diagnostic odds ratio (DOR) of adenosine deaminase for diagnosing tuberculous pericarditis were pooled, and the summary receiver operating characteristic (SROC) curves were used to examine the overall performance of adenosine deaminase.
RESULTS: In total, 11 studies with 938 subjects were included in the meta-analysis. The summary estimates of adenosine deaminase for diagnosing tuberculous pericarditis were listed as follows: sensitivity of 0.90 (95% CI: 0.86-0.93), specificity of 0.86 (95% CI: 0.83-0.89), PLR of 5.90 (95% CI: 4.46-7.82), NLR of 0.15 (95% CI: 0.09-0.26), and DOR of 42.55 (95% CI: 21.51-84.18). The area under the SROC curve was 0.92, and the Q value was 0.85. No publication bias was identified.
CONCLUSIONS: Adenosine deaminase is a valuable marker with both high sensitivity and specificity in the diagnosis of tuberculous pericarditis. Nevertheless, the results of adenosine deaminase assays should be interpreted in combination with other test results and clinical characteristics of patients.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26636531

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  6 in total

Review 1.  Tuberculous pericardial disease: a focused update on diagnosis, therapy and prevention of complications.

Authors:  Kishendree Naicker; Mpiko Ntsekhe
Journal:  Cardiovasc Diagn Ther       Date:  2020-04

2.  Diagnostic accuracy of interferon-gamma in pericardial effusions for tuberculous pericarditis: a meta-analysis.

Authors:  Chao Liu; Yun-Liang Cui; Chun-Mei Ding; Yan-Hua Wu; Hui-Li Li; Xiao-Fei Liu; Zhi-De Hu
Journal:  J Thorac Dis       Date:  2018-02       Impact factor: 2.895

3.  Comparison between the diagnostic validities of Xpert MTB/RIF and interferon-γ release assays for tuberculous pericarditis using pericardial tissue.

Authors:  Guocan Yu; Bo Ye; Da Chen; Fangming Zhong; Gang Chen; Jun Yang; Liliang Xu; Xudong Xu
Journal:  PLoS One       Date:  2017-12-06       Impact factor: 3.240

Review 4.  Diagnosis and Management of Tuberculous Pericarditis: What Is New?

Authors:  Godsent Isiguzo; Elsa Du Bruyn; Patrick Howlett; Mpiko Ntsekhe
Journal:  Curr Cardiol Rep       Date:  2020-01-15       Impact factor: 2.931

5.  Diagnostic values of Xpert MTB/RIF, T-SPOT.TB and adenosine deaminase for HIV-negative tuberculous pericarditis in a high burden setting: a prospective observational study.

Authors:  Xu Hu; Baochun Xing; Wei Wang; Pengwei Yang; Yumei Sun; Xiangyang Zheng; Yaomin Shang; Feifei Chen; Nai Liu; Lu Yang; Yue Zhao; Jiao Tan; Xueya Zhang; Yan Wang; Zhengxun Zhang; Yaqian Liu
Journal:  Sci Rep       Date:  2020-10-01       Impact factor: 4.379

6.  Serum Biomarker Profile Including CCL1, CXCL10, VEGF, and Adenosine Deaminase Activity Distinguishes Active From Remotely Acquired Latent Tuberculosis.

Authors:  Eveline M Delemarre; Laura van Hoorn; Aik W J Bossink; Julia Drylewicz; Simone A Joosten; Tom H M Ottenhoff; Onno W Akkerman; Delia Goletti; Elisa Petruccioli; Assunta Navarra; Brigitte T A van den Broek; Sanne P A Paardekooper; Ineke van Haeften; Leo Koenderman; Jan-Willem J Lammers; Steven F T Thijsen; Regina W Hofland; Stefan Nierkens
Journal:  Front Immunol       Date:  2021-10-07       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.